Areej A Alhareeri, Kellie J Archer, Han Fu, Debra E Lyon, R K Elswick, Debra L Kelly, Angela R Starkweather, Lynne W Elmore, Yahya A Bokhari, Colleen K Jackson-Cook
BACKGROUND: Survival rates for breast cancer (BC) have improved, but quality of life post-diagnosis/treatment can be adversely affected, with survivors reporting a constellation of psychoneurological symptoms (PNS) including stress, anxiety, depression, pain, fatigue, sleep disturbance, and cognitive dysfunction. METHODS: To assess a potential relationship between telomere length (TL) and the development/persistence of PNS, we longitudinally studied 70 women (ages 23-71) with early stage BC (I-IIIA) at 5 time-points: prior to treatment (baseline), the mid-point of their chemotherapy cycle, 6 months, 1 year, and 2 years following the initiation of chemotherapy...
December 4, 2020: Breast Cancer Research: BCR